1.
|
JM JezTG FlynnTM PenningA new nomenclature
for the aldo-keto reductase superfamilyBiochem
Pharmacol54639647199710.1016/S0006-2952(97)84253-09310340
|
2.
|
P Anil KumarG Bhanuprakash ReddyFocus on
molecules: aldose reductaseExp Eye Res85739740200716997295
|
3.
|
M LorenziThe polyol pathway as a mechanism
for diabetic retinopathy: attractive, elusive, and resilientExp
Diabetes Res200761038200710.1155/2007/6103818224243
|
4.
|
C Yabe-NishimuraAldose reductase in
glucose toxicity: a potential target for the prevention of diabetic
complicationsPharmacol Rev50213319989549756
|
5.
|
A PladzykKV RamanaNH AnsariSK
SrivastavaAldose reductase prevents aldehyde toxicity in cultured
human lens epithelial cellsExp Eye
Res83408416200610.1016/j.exer.2006.01.01916631166
|
6.
|
KV RamanaAB ReddyR TammaliSK
SrivastavaAldose reductase mediates endotoxin-induced production of
nitric oxide and cytotoxicity in murine macrophagesFree Radic Biol
Med4212901302200710.1016/j.freeradbiomed.2007.01.03317382209
|
7.
|
R RamasamyIJ GoldbergAldose reductase and
cardiovascular diseases, creating human-like diabetic complications
in an experimental modelCirc
Res10614491458201010.1161/CIRCRESAHA.109.21344720466987
|
8.
|
P AlexiouK PegklidouM ChatzopoulouI
NicolaouVJ DemopoulosAldose reductase enzyme and its implication to
major health problems of the 21st centuryCurr Med
Chem16734752200910.2174/09298670978745836219199934
|
9.
|
KV RamanaSK SrivastavaAldose reductase: a
novel therapeutic target for inflammatory pathologiesInt J Biochem
Cell Biol421720201010.1016/j.biocel.2009.09.00919778627
|
10.
|
R TammaliKV RamanaSS SinghalS AwasthiSK
SrivastavaAldose reductase regulates growth factor-induced
cyclooxygenase-2 expression and prostaglandin E2 production in
human colon cancer cellsCancer
Res6697059713200610.1158/0008-5472.CAN-06-2105
|
11.
|
Q CheT JiangYF LinH LiN ZhangEffects of
aldose reductase transfection on the proliferation of rat mesangial
cells in vitroZhonghua Bing Li Xue Za Zhi344174202005(In
Chinese).
|
12.
|
WG CouserPathogenesis of glomerular damage
in glomerulonephritisNephrol Dial Transplant13Suppl
1S10S15199810.1093/ndt/13.suppl_1.10
|
13.
|
RJ JohnsonJ FloegeWG CouserCE AlpersRole
of platelet-derived growth factor in glomerular diseaseJ Am Soc
Nephrol411912819938311852
|
14.
|
F DasL MahimainathanN
Ghosh-ChoudhuryTGFbeta intercepts nuclear glycogen synthase kinase
3beta to inhibit PDGF-induced DNA synthesis in mesangial cellsFEBS
Lett58152595267200710.1016/j.febslet.2007.10.01417961557
|
15.
|
J FloegeF EitnerCE AlpersA new look at
platelet-derived growth factor in renal diseaseJ Am Soc
Nephrol191223200810.1681/ASN.200705053218077793
|
16.
|
RE GilbertDJ KellyT McKayPDGF signal
transduction inhibition ameliorates experimental mesangial
proliferative glomerulonephritisKidney
Int5913241332200110.1046/j.1523-1755.2001.0590041324.x
|
17.
|
RP DirksHP BloemersSignals controlling the
expression of PDGFMol Biol Rep22124199510.1007/BF00996300
|
18.
|
GG ChoudhuryC KaramitsosJ HernandezA
GentiliniJ BardgetteHE AbboudPI-3-kinase and MAPK regulate
mesangial cell proliferation and migration in response to PDGFAm J
Physiol273F931F93819979435682
|
19.
|
A Cove-SmithBM HendryThe regulation of
mesangial cell proliferationNephron Exp
Nephrol108e74e79200810.1159/00012735918431073
|
20.
|
M CampbellER TrimbleModification of PI3K-
and MAPK-dependent chemotaxis in aortic vascular smooth muscle
cells by protein kinase CbetaIICirc
Res96197206200510.1161/01.RES.0000152966.88353.9d15591231
|
21.
|
UC YadavL Aguilera-AguirreKV RamanaI
BoldoghSK SrivastavaAldose reductase inhibition prevents metaplasia
of airway epithelial cellsPLoS
One5e14440201010.1371/journal.pone.001444021203431
|
22.
|
GG ChoudhuryAkt serine threonine kinase
regulates platelet-derived growth factor-induced DNA synthesis in
glomerular mesangial cells: regulation of c-fos AND p27(kip1) gene
expressionJ Biol Chem2763563635643200110.1074/jbc.M100946200
|
23.
|
CB MarshallSJ ShanklandCell cycle and
glomerular disease: a minireviewNephron Exp
Nephrol102e39e48200610.1159/00008840016179806
|
24.
|
SJ ShanklandG WolfCell cycle regulatory
proteins in renal disease: role in hypertrophy, proliferation, and
apoptosisAm J Physiol Renal Physiol278F515F529200010751212
|
25.
|
A BhatnagarJ RuefS LiuS SrivastavaSK
SrivastavaRegulation of vascular smooth muscle cell growth by
aldose reductaseChem Biol Interact130–132627636200111306081
|
26.
|
HT HoSK ChungJW LawAldose
reductase-deficient mice develop nephrogenic diabetes insipidusMol
Cell Biol2058405846200010.1128/MCB.20.16.5840-5846.200010913167
|
27.
|
T JiangQ CheY LinH LiN ZhangAldose
reductase regulates TGF-beta1-induced production of fibronectin and
type IV collagen in cultured rat mesangial cellsNephrology
(Carlton)11105112200610.1111/j.1440-1797.2006.00553.x16669970
|
28.
|
KV RamanaD ChandraS SrivastavaA
BhatnagarSK SrivastavaAldose reductase mediates the mitogenic
signals of cytokinesChem Biol Interact143–144587596200312604244
|
29.
|
Y KasuyaJ NakamuraY HamadaAn aldose
reductase inhibitor prevents the glucose-induced increase in
PDGF-beta receptor in cultured rat aortic smooth muscle
cellsBiochem Biophys Res
Commun261853858199910.1006/bbrc.1999.111110441515
|
30.
|
K IshizawaN DorjsurenY
Izawa-IshizawaInhibitory effects of adiponectin on platelet-derived
growth factor-induced mesangial cell migrationJ
Endocrinol202309316200910.1677/JOE-08-046919460854
|
31.
|
HO SchocklmannS LangM KralewskiA HartnerA
LudkeRB SterzelDistinct structural forms of type I collagen
modulate cell cycle regulatory proteins in mesangial cellsKidney
Int5811081120200010.1046/j.1523-1755.2000.00268.x10972675
|
32.
|
A PapapetropoulosD FultonK
MahboubiAngiopoietin-1 inhibits endothelial cell apoptosis via the
Akt/survivin pathwayJ Biol
Chem27591029105200010.1074/jbc.275.13.910210734041
|
33.
|
SK BiswasY ZhaoL SandirasegaraneImatinib
induces apoptosis by inhibiting PDGF- but not insulin-induced PI
3-kinase/Akt survival signaling in RGC-5 retinal ganglion cellsMol
Vis1515991610200919693287
|
34.
|
KV RamanaR TammaliSK SrivastavaInhibition
of aldose reductase prevents growth factor-induced G1-S phase
transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway
in human colon cancer cellsMol Cancer
Ther9813824201010.1158/1535-7163.MCT-09-0795
|
35.
|
D MitchellK RodgersJ HanlyLipoxins inhibit
Akt/PKB activation and cell cycle progression in human mesangial
cellsAm J
Pathol164937946200410.1016/S0002-9440(10)63181-114982847
|
36.
|
B VenkatesanN Ghosh-ChoudhuryF
DasResveratrol inhibits PDGF receptor mitogenic signaling in
mesangial cells: role of PTP1BFASEB
J2234693482200810.1096/fj.08-10948818567737
|
37.
|
SJ ShanklandCell-cycle control and renal
diseaseKidney Int52294308199710.1038/ki.1997.3359263984
|
38.
|
CJ SherrJM RobertsInhibitors of mammalian
G1 cyclin-dependent kinasesGenes
Dev911491163199510.1101/gad.9.10.11497758941
|
39.
|
SS GhoshTW GehrS GhoshPPARgamma ligand
attenuates PDGF-induced mesangial cell proliferation: role of MAP
kinaseKidney
Int645262200310.1046/j.1523-1755.2003.00054.x12787395
|
40.
|
A YoshimuraT NemotoY SugenoyaEffect of
simvastatin on proliferative nephritis and cell-cycle protein
expressionKidney Int
Suppl71S84S87199910.1046/j.1523-1755.1999.07121.x10412745
|
41.
|
Q FengS HuangA ZhangY-box protein 1
stimulates mesangial cell proliferation via activation of
ERK1/2Nephron Exp Nephrol113e16e25200910.1159/00022807919590238
|